Functional Characterization Experiment summary for ENCSR077WEU

doi:10.17989/ENCSR077WEU

Summary

Status
released
Assay
proliferation CRISPR screen
Biosample summary
Homo sapiens K562 genetically modified (insertion) using transduction (low MOI), using CRISPR cutting (sgRNA) for MYC locus
Biosample Type
cell line
Perturbation type
CRISPR cutting
Tiling modality
peak tiling
Replication type
isogenic
Description
CRISPR screen targeting candidate CREs following survival
Treatments
Puromycin (CHEBI:17939)
Nucleic acid type
DNA
Controls
Elements references
Elements cloning
ENCSR903VDF

Attribution

ENCODE4 project
Lab
Yin Shen, UCSF
Award
UM1HG009402 (Yin Shen, UCSF)
Project
ENCODE
Aliases
yin-shen:DCC_K562_MYC_GFP_MYC_Screening_survival_Experiment
Date released
August 30, 2021
Functional Characterization Series
ENCSR042KBK 

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Modifications
Library
11Homo sapiens K562 cell line genetically modified (insertion) using transduction (low MOI), genetically modified using CRISPR cutting (sgRNA) 14 days after the sample was treated with PuromycinENCBS501PJOENCGM063WJB, ENCGM885GEZENCLB871HGX
21Homo sapiens K562 cell line genetically modified (insertion) using transduction (low MOI), genetically modified using CRISPR cutting (sgRNA) 14 days after the sample was treated with PuromycinENCBS892SNMENCGM063WJB, ENCGM885GEZENCLB016HLB